On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
How a Maine Program Reduced Heart Disease
Community-wide programs to help residents reduce their risk factors for cardiovascular disease (CVD) have had sporadic success. In rural Maine, however, such an effort has had sustained results lasting over a 40-year period, N. Burgess Record, MD and colleagues report in the Journal of the American Medical Association.
Heart Disease: Too Much Aspirin?
Preventing cardiovascular disease (CVD) is an important goal in population health. But according to American Heart Association guidelines on primary prevention of CVD, recommending that all healthy people take aspirin to do that is not the way to go. In a new study in the Journal of the American College of Cardiology, however, Ravi Hira, MD and colleagues find that not all physicians have gotten the message. The researchers looked at the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry. Of 68,808 patients, 11.6% were taking aspirin inappropriately, the team found.
Metformin: Multitasking Medicine
January 12th 2015Tuberculosis (TB) kills 1.43 million people annually. Effective TB treatment is challenging, due to the mycobacterial cell wall's unusual structure and chemical composition -- the wall repels drugs efficiently and renders many antibiotics ineffective. An article in Science Translational Medicine describes a drug that may have potential to alter host response to TB: the antidiabetic agent metformin.
Changes in Recommendations for Surgeries of the Colon and Rectum
January 12th 2015Surgical management of colon and rectum diseases changes quite quickly. Noting that many changes have been suggested in just the last year, 2 surgeons from the Mayo Clinic in Rochester, Minnesota, assembled a review of the most significant. This paper appears in the January 2015 issue of Current Opinions in Gastroenterology.
Care Fragmentation: Affecting the Elderly Disproportionately
January 12th 2015Fragmentation -- a lack of care continuity when disparate healthcare professionals provide care without integrated access to clinical information -- is a public health focus. It's a concern for surgeons when patients undergo complex procedures that require lengthy periods of recovery. Fragmentation is especially troubling when patients are elderly.
Interferon-free Combination Therapy Can Prevent Post-transplant HCV Recurrence
Following 2 recent studies published in Gastroenterology, researchers reported that a 24-week course of sofosbuvir and ribavirin could eliminate hepatitis C virus (HCV) infection in two-thirds of patients who undergo liver transplantation.
Expert Witnesses: Are the Guidelines Acceptable?
January 12th 2015Surgeons from several leading medical schools in the United States gathered expert witness guidelines among major surgical societies for review. They looked for gaps in the standards to stimulate discussion about areas for improvement. Their review provides an educational look at the surgeon's role in the judicial system.
FDA Approves New Enteral Treatment for Parkinson's Disease
DUOPA (carbidopa and levodopa) enteral suspension for the treatment of motor fluctuations for people with advanced Parkinson's disease is administered via portable infusion pump that delivers carbidopa and levodopa directly into the small intestine for 16 continuous hours.
Recent Deaths from Anaphylaxis Underscore Need for Preparedness, Education
Four separate cases of fatal anaphylaxis, all within days of each other, vividly illustrate both the extreme difficulty of avoiding known food allergens and the potential consequences of any given exposure.